Evidence map›Paper›PMID 40868242›Full record

ArticleBiomedicines2025

Exploring Multidimensional Risk Factors Associated with Local Adverse Reactions to Subcutaneous Immunoglobulin Therapy: Insights from a Nationwide Multicenter Study.

Sandra Martínez Mercader, Victor Garcia-Bustos, Pedro Moral Moral, Carmen Martínez Buenaventura, Elisa Escudero Vergara, María Carmen Montaner Bosch, Héctor Balastegui-Martín, Sonia Galindo Maycas, Miriam González Amores, Noemí Gimenez Sanz and 8 more

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sandra Martínez MercaderPrimary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
Victor Garcia-BustosPrimary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
Pedro Moral MoralPrimary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
Carmen Martínez BuenaventuraPrimary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
Elisa Escudero VergaraPrimary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
María Carmen Montaner BoschPrimary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
Héctor Balastegui-MartínPrimary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
Sonia Galindo MaycasPediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Miriam González AmoresInfection and Immunity in Pediatric Patients Research Group, Vall d'Hebron Institut de Recerca, 08035 Barcelona, Spain.
Noemí Gimenez SanzInfection and Immunity in Pediatric Patients Research Group, Vall d'Hebron Institut de Recerca, 08035 Barcelona, Spain.
Marian Escobar PalazónArea of Immunology-Multidisciplinary Day Hospital, Gregorio Marañón General University Hospital, 28007 Madrid, Spain.
María Moreno MuletArea of Immunology-Multidisciplinary Day Hospital, Gregorio Marañón General University Hospital, 28007 Madrid, Spain.
Ignacio Campanero CarrascoImmunology Day Hospital Unit, Reina Sofía University Hospital, 14004 Córdoba, Spain.
Alicia LópezOnco-Hematology Day Hospital, La Paz University Hospital, 28046 Madrid, Spain.
Carlos Daniel Hernández RuizInternal Medicine Day Hospital, Doctor Negrín University Hospital of Gran Canaria, 35010 Gran Canaria, Spain.
Laura Ruiz-LópezClinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain.
Rocío Guzmán GuzmánDay Hospital, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.
Marta Dafne Cabañero-NavalonPrimary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

common variable immunodeficiency (CVID)immunoglobulin replacement therapy (IgRT)intravenous immunoglobulin (IVIg)real-world evidencesubcutaneous immunoglobulin (SCIg)

Identifiers

PMID40868242
PMCPMC12383288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.